AI reads prostate scans to predict survival
NCT ID NCT06363435
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether an artificial intelligence (AI) system can automatically measure the amount of cancer seen on PSMA PET-CT scans in 1,500 men with prostate cancer. The AI will calculate tumor volume and uptake, and researchers will see if these measurements can predict how long patients live or when the cancer might come back. The AI results are not used to guide patient care during the study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a reliable AI tool that helps doctors better predict outcomes for prostate cancer patients using standard scans.
What could go wrong
This is an observational study, not a treatment trial. The AI method is not yet proven to improve patient care, and results may not apply to all hospitals or scanners.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Skåne University Hospital
RECRUITINGLund, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Skåne university hospital
RECRUITINGMalmö, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••